Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Sequentia Biotech

Explore full profile

Sequentia Biotech developed MICK, a digital decision support system helping healthcare professionals in integrating microbiome analysis into clinical practice

Barcelona, SpainFounded 2013Biotech & Life Sciences
Valuation $25–50M Last recorded · 2024
Revenue $1–10M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Sequentia Biotech and the history behind them.

About Sequentia Biotech

Operator of a bioinformatics company intended to transform omics data into knowledge. The company collaborates with research centers, universities and businesses to offer cloud software, custom software and bioinformatics consulting services for healthcare, pharma, agriculture, industry and environment, enabling clients to utilize omics sciences for achieving a breakthrough in the fields of human health, agriculture and the environment. Keywords: Pharmaceuticals and Biotechnology, Bioinformatics, Bioinformatics Analysis, Bioinformatics Company, Bioinformatics Data, Bioinformatics Research, Bioinformatics System.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2013
Headquarters
Barcelona, Spain
Employees
48
Open positions
None listed
Dealroom signal
67.5/100
Industry
Health
Sub-industry
BioTechnology, Health Platform
Sector
Biotech & Life Sciences, Analytics, Biotechnology, Genetics and genomics, Molecular Biology, Core AI, Precision Medicine
Technology
Artificial Intelligence, Big Data, Machine Learning
Business model
SaaS
Client focus
b2b

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing Sep 2024 $11M $44M Seventure Partners · EIC Fund ↗
GRANTOther financing Oct 2021 $2.2M — European Innovation Council —
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Sequentia Biotech website traffic

Latest recorded traffic for Sequentia Biotech is 2.6K monthly website visits, up 4% over the last three months. Sequentia Biotech's team grew 2.1% over the past year.

Latest monthly visits2.6K 3-month web change+4% 1-year team growth+2.1%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • European Innovation Council

Series A2 investors entered at this stage

  • EIC Fund
  • Seventure Partners

Other known investors2 additional known investors

  • Centre for Genomic Regulation
  • Centre for Research in Agricultural Genomics
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇪🇸 Spain80.6%
🇮🇹 Italy11.1%
🇵🇹 Portugal5.6%
🇯🇵 Japan2.8%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Sequentia Biotech on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Sequentia Biotech’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.